CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Net Income	$ (204,476)	$ 47,723
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion, and amortization	272,742	201,663
Deferred income taxes	(62,898)	3,129
Share-based compensation	20,511	37,910
(Gain) loss on the disposal of property, plant, and equipment, and intangibles, net	(50)	537
Loss on sale of businesses, net	4,777	404
Fair value adjustment related to convertible debt liability	0	27,806
Amortization of inventory fair value adjustments	2,477	85,154
2591744000	490,565	0
Other items	8,840	7,986
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable, net	(2,976)	15,932
Inventories, net	(97,987)	(57,897)
Other current assets	1,269	(66,337)
Accounts payable	15,675	(260)
Accruals and other, net	(112,899)	(34,984)
Net cash provided by operating activities	335,570	268,766
Investing activities:
Purchases of property, plant, equipment, and intangibles, net	(198,701)	(133,369)
Proceeds from the sale of property, plant, equipment, and intangibles	1,323	387
Proceeds from Divestiture of Businesses, Net of Cash Divested	5,228	0
Acquisition of businesses, net of cash acquired	(15,192)	(547,353)
Net cash used in investing activities	(207,342)	(680,335)
Financing activities:
Proceeds from Issuance of Senior Long-term Debt	0	1,350,000
Proceeds from Issuance of Secured Debt	0	650,000
Payments on long-term obligations	0	(721,284)
Repayments of Convertible Debt	0	(371,361)
Repayments of Secured Debt	(126,875)	(125,000)
Proceeds (Payments) under credit facilities, net	99,111	(65,021)
Deferred financing fees and debt issuance costs	0	(17,343)
Acquisition related deferred or contingent consideration	(153)	(25,262)
Repurchases of ordinary shares	(69,922)	(24,751)
Cash dividends paid to ordinary shareholders	(89,981)	(77,107)
Payments to Noncontrolling Interests	0	(997)
Proceeds from (Payments for) Other Financing Activities	1,458	7,829
Net cash used in financing activities	(186,362)	579,703
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(31,927)	(5,171)
Increase (decrease) in cash and cash equivalents	(90,061)	162,963
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	$ 258,259	$ 383,494